UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C.  20549

 

 

 

 

FORM 8-K/A

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

 

 

      Date of Report (Date of earliest event reported): June 7, 2004

 

 

EPIX Medical, Inc.

 (Exact name of registrant as specified in its charter)

 

 

 

 

71 Rogers Street
Cambridge, Massachusetts 02142

 (Address of principal executive offices) (Zip Code)

 

 

      Registrant’s telephone number, including area code: (617) 250-6000

 

 

Item 5.   Other Events and Regulation FD Disclosure.

 

Explanatory Note:

 

This Form 8-K/A is filed to amend the Form 8-K filed with the Securities and Exchange Commission on June 7, 2004 by EPIX Medical, Inc., describing the completion of a private offering of $100 million aggregate principal amount of the company’s 3.00% Convertible Senior Notes due 2024 (the “Original 8-K”).  This Form 8-K/A amends the Signatures section of the Original 8-K to conform the same to the Signatures section of this report.

 

2

 

SIGNATURES

 

                Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

	EPIX Medical, Inc.
	(Registrant)
Date: June 7, 2004	/s/ Peyton J. Marshall
	Peyton J. Marshall
	Senior Vice President,
	Finance and Administration,
	Chief Finance Officer

 

3